Cargando…
Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
BACKGROUND: Intravenous tissue plasminogen activator (IV t-PA) is effective for the treatment of distal artery occlusion. However, after the use of IV t-PA, vascular occlusion in unaffected territories may occur. Early recurrent ischemic stroke (ERIS) is defined as the occurrence of new neurological...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Neurological Surgeons
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394676/ https://www.ncbi.nlm.nih.gov/pubmed/36046799 http://dx.doi.org/10.3171/CASE20175 |
_version_ | 1784771530977181696 |
---|---|
author | Sugie, Akira Yamada, Makoto Yokoyama, Kunio Miyake, Tomoaki Ito, Yutaka Tanaka, Hidekazu Nomura, Yukiya Fujita, Masutsugu Nakatani, Toshio Kawanishi, Masahiro |
author_facet | Sugie, Akira Yamada, Makoto Yokoyama, Kunio Miyake, Tomoaki Ito, Yutaka Tanaka, Hidekazu Nomura, Yukiya Fujita, Masutsugu Nakatani, Toshio Kawanishi, Masahiro |
author_sort | Sugie, Akira |
collection | PubMed |
description | BACKGROUND: Intravenous tissue plasminogen activator (IV t-PA) is effective for the treatment of distal artery occlusion. However, after the use of IV t-PA, vascular occlusion in unaffected territories may occur. Early recurrent ischemic stroke (ERIS) is defined as the occurrence of new neurological symptoms that suggest the involvement of initially unaffected vascular territories after intravenous thrombolysis (IVT). The authors reviewed the cases of ERIS that occurred within 24 hours after treatment with IVT. OBSERVATIONS: A 75-year-old woman with occlusion in the M2 segment of the left middle cerebral artery (MCA) was treated with IV t-PA. However, 360 minutes later, the patient presented with occlusion in the M1 distal segment of the contralateral side, the right MCA, which was recanalized by endovascular treatment. Her modified Rankin Scale score was 4; however, aphasia was not observed. She was transferred to a rehabilitation hospital after 3 months. LESSONS: ERIS is an extremely rare but catastrophic event. The underlying mechanism of ERIS most likely involves the disintegration and subsequent scattering of a preexisting intracardiac thrombus. Hence, caution must be used when managing not only hemorrhagic complications but also ischemic complications after IV t-PA. Endovascular management may be the only effective treatment for this type of large vessel occlusion. |
format | Online Article Text |
id | pubmed-9394676 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Association of Neurological Surgeons |
record_format | MEDLINE/PubMed |
spelling | pubmed-93946762022-08-30 Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case Sugie, Akira Yamada, Makoto Yokoyama, Kunio Miyake, Tomoaki Ito, Yutaka Tanaka, Hidekazu Nomura, Yukiya Fujita, Masutsugu Nakatani, Toshio Kawanishi, Masahiro J Neurosurg Case Lessons Case Report BACKGROUND: Intravenous tissue plasminogen activator (IV t-PA) is effective for the treatment of distal artery occlusion. However, after the use of IV t-PA, vascular occlusion in unaffected territories may occur. Early recurrent ischemic stroke (ERIS) is defined as the occurrence of new neurological symptoms that suggest the involvement of initially unaffected vascular territories after intravenous thrombolysis (IVT). The authors reviewed the cases of ERIS that occurred within 24 hours after treatment with IVT. OBSERVATIONS: A 75-year-old woman with occlusion in the M2 segment of the left middle cerebral artery (MCA) was treated with IV t-PA. However, 360 minutes later, the patient presented with occlusion in the M1 distal segment of the contralateral side, the right MCA, which was recanalized by endovascular treatment. Her modified Rankin Scale score was 4; however, aphasia was not observed. She was transferred to a rehabilitation hospital after 3 months. LESSONS: ERIS is an extremely rare but catastrophic event. The underlying mechanism of ERIS most likely involves the disintegration and subsequent scattering of a preexisting intracardiac thrombus. Hence, caution must be used when managing not only hemorrhagic complications but also ischemic complications after IV t-PA. Endovascular management may be the only effective treatment for this type of large vessel occlusion. American Association of Neurological Surgeons 2021-04-12 /pmc/articles/PMC9394676/ /pubmed/36046799 http://dx.doi.org/10.3171/CASE20175 Text en © 2021 The authors https://creativecommons.org/licenses/by-nc-nd/4.0/CC BY-NC-ND 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Case Report Sugie, Akira Yamada, Makoto Yokoyama, Kunio Miyake, Tomoaki Ito, Yutaka Tanaka, Hidekazu Nomura, Yukiya Fujita, Masutsugu Nakatani, Toshio Kawanishi, Masahiro Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case |
title | Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case |
title_full | Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case |
title_fullStr | Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case |
title_full_unstemmed | Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case |
title_short | Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case |
title_sort | vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394676/ https://www.ncbi.nlm.nih.gov/pubmed/36046799 http://dx.doi.org/10.3171/CASE20175 |
work_keys_str_mv | AT sugieakira vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT yamadamakoto vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT yokoyamakunio vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT miyaketomoaki vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT itoyutaka vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT tanakahidekazu vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT nomurayukiya vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT fujitamasutsugu vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT nakatanitoshio vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase AT kawanishimasahiro vascularocclusioninapreviouslyunaffectedterritoryaftertreatmentwithintravenousplasminogenactivatorillustrativecase |